A sobering reminder of this was provided in recent reports of the occurrence of PML in association with efalizumab. 1 Efalizumab was originally approved by the FDA in 2003 for the treatment of ...

The risk of PML can potentially be reduced by: Ocrevus has brought hope to many MS patients, offering effective treatment ...

APL is a distinct subtype of myeloid leukaemia that in almost 100% of cases is associated with chromosomal translocations involving the PML and retinoic acid receptor α (RARA) loci, leading to ...